At close: December 20 at 5:29:55 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-7,950.0000
-26,219.0000
-35,592.0000
-42,641.0000
-27,420.0000
Investing Cash Flow
-115.0000
-282.0000
-810.0000
-2,401.0000
-3,746.0000
Financing Cash Flow
-280.0000
34,755.0000
7,657.0000
42,973.0000
59,637.0000
End Cash Position
8,749.0000
13,512.0000
5,258.0000
34,003.0000
36,073.0000
Capital Expenditure
-115.0000
-282.0000
-811.0000
-2,402.0000
-3,746.0000
Issuance of Capital Stock
--
42,239.0000
4,500.0000
45,169.0000
67,407.0000
Issuance of Debt
--
--
6,620.0000
--
--
Repayment of Debt
--
-4,000.0000
-2,660.0000
--
--
Free Cash Flow
-8,065.0000
-26,501.0000
-36,403.0000
-45,043.0000
-31,166.0000
12/31/2020 - 7/31/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NANECH.ST NanoEcho AB
0.1580
+21.54%
QUIA.ST Quia Pharma AB (publ)
0.0172
+3.61%
COMBI.ST CombiGene AB (publ)
2.7200
+5.43%
DIABIO.ST Diagonal Bio AB (publ)
0.0258
+5.31%
PCIB.OL PCI Biotech Holding ASA
1.3200
-7.04%
ZICC.ST Ziccum AB (publ)
0.3830
-6.36%
CRNA.OL Circio Holding ASA
0.7080
-3.28%
ULTI.OL Ultimovacs ASA
2.5500
-3.77%
FLUI.ST Fluicell AB (publ)
0.0412
-1.90%
ISOFOL.ST Isofol Medical AB (publ)
2.4050
-3.80%